Back to search

Article

Melanoma Brain Metastases Patient-Derived Organoids: an <em>in Vitro</em> Platform for Drug Screening

2024-07-08

Abstract excerpt

<h4>Background: </h4> and aims: Brain metastases are prevalent in the late stages of malignant melanoma. Multimodal therapy remains challenging. Patient-derived organoids (PDOs) represent a valuable pre-clinical model, faithfully recapitulating key aspects of the original tumor, including the heterogeneity and the mutational status. This study aimed to establish PDOs from melanoma brain metastases (MBM-PDOs) and t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fa547d8f-d0cc-526e-a5a6-37b0904a4d53
DOI
10.20944/preprints202407.0598.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Melanoma Brain Metastases Patient-Derived Organoids: an <em>in Vitro</em> Platform for Drug ScreeningDOI 10.20944/preprints202407.0598.v1
Select a neighboring publication to make it the new centre.